ADC Therapeutics (ADCT) Conference February 06, 2025 02:00 PM ET Company Participants Ameet Mallik - CEO Conference Call Participants Michael Schmidt - Senior Managing Director & Equity Research Analyst - Biotechnology Michael Schmidt All right. So welcome to this next fireside chat with ADC Therapeutics. My name is Michael Schmidt, biotech analyst with Guggenheim. And with me today, I have Amit Malik, CEO of ADC And so, Amit, welcome. Thanks for joining us. Ameet Mallik Thank you. Michael Schmidt So just a ...

Lexeo Therapeutics (LXEO) Conference February 06, 2025 01:30 PM ET Company Participants Debjit Chattopadhyay - Managing DirectorKyle Rasbach - CFOSandi See Tai - Chief Development Officer Debjit Chattopadhyay Alright. Good afternoon, and thank you for joining Guggenheim Therapeutics team, on our second Smith Gap Conference. I am Devjit, one of the therapeutic analysts. And joining me on stage from Lexio Therapeutics are Sandy C. Sai, chief development officer, and Kyle Raschbach, CFO. Thank you for making t ...

Centessa Pharmaceuticals (CNTA) Conference February 06, 2025 01:00 PM ET Company Participants Debjit Chattopadhyay - Managing DirectorMario Accardi - President of the Orexin Program Debjit Chattopadhyay Good afternoon, and thank you for joining Guggenheim's second, Smithcap conference. I am Devchit, and joining me from Syntesa is Mario Carty, the president of the Orexin program. Did I get that right? Mario Accardi You did. Yes, Doug. Hi. Great to be here with you. Debjit Chattopadhyay Well, it's been a very ...

Arqit Quantum (ARQQ) Update / Briefing February 06, 2025 10:00 AM ET Company Participants Andy Leaver - CEO Conference Call Participants Scott Buck - Managing Director & Senior Technology Analyst Scott Buck morning, everyone. My name is Scott Buck. I'm a Technology Research Analyst here at H. C. Wainwright. I want to welcome everyone joining us for our conversation with Artec Quantum Chief Executive Officer, Andy Lieber. Before we get started, I want to read through the company's Safe Harbor statements. Ple ...

Kymera Therapeutics (KYMR) Conference February 06, 2025 10:00 AM ET Company Participants Nello Mainolfi - Co-Founder, President, CEO & Director Conference Call Participants Michael Schmidt - Senior Managing Director & Equity Research Analyst - Biotechnology Michael Schmidt Michael Schmidt, senior biotic analyst with Guggenheim, and I'd like to welcome, Nelo Manolfi, the founder, president, and CEO of Chimera to this next fireside chat. Nelo, welcome and thanks for joining us. Nello Mainolfi Thanks, Michael, ...

Phathom Pharmaceuticals (PHAT) Conference February 06, 2025 10:00 AM ET Company Participants Azmi Nabulsi - Co-Founder & COOMartin Gilligan - Chief Commercial Officer Conference Call Participants Yatin Suneja - Biotechnology Research Analyst Yatin Suneja Good morning, everyone. My name is Yatin Suneja. I am one of the biotech analysts here at Guggenheim. It is my pleasure to welcome our next presenting company, Fathom, to our SMITCAP Biotech Conference. We have a few members here from the company. We have M ...

Dianthus Therapeutics (DNTH) Conference February 06, 2025 09:00 AM ET Company Participants Marino Garcia - President, CEO, Secretary & Director Conference Call Participants Yatin Suneja - Biotechnology Research Analyst Yatin Suneja Good morning, everyone. My name is Yatin Suneja, one of the biotech analysts here at Guggenheim. Welcome to our SMITCAP Biotech Conference. It is my pleasure to introduce our our first presenting company of the day, Dianthus. From the company, we have Marino Garcia, who is the Ch ...

Tarsus Pharmaceuticals (TARS) Conference February 06, 2025 09:00 AM ET Company Participants Eddie Hickman - Vice PresidentJeff Farrow - CFO Eddie Hickman Good morning, everyone. Welcome back to the twenty twenty five Guggenheim's MidCap Biotech Conference. My name is Eddie Hickman and I'm one of the analysts here. I'm joined here by Tarsus Pharmaceutical CFO, Jeff Ferro. Thank you for being here, Jeff. Exciting year for Tarsus, the launch of Extemvy and the recent announcement of a new product and another n ...

The Buckle (BKE) Update / Briefing February 05, 2025 07:00 PM ET Company Participants Adam Akerson - VP of Finance, Controller & Assistant Treasurer Adam Akerson Hi. This is Adam Ackerson with Buckle, and this is a recording of Buckle's commentary regarding the company's January 2025 sales press release. Our 02/06/2025 press release reported that comparable store sales for stores opened at least one full year for the four week period ended 02/01/2025, increased 4.4% in comparison to the prior year four week ...

Costco Wholesale (COST) 2025 Update / Briefing February 05, 2025 04:00 PM ET Company Participants Josh Dahmen - Assistant Vice President of Financial Planning & Investor Relations Josh Dahmen Hello. I'm Josh Damon, AVP of Finance and Investor Relations, and I will review our sales results for the four week retail month of January, which started on Monday, January 6 and ended on Sunday, February 2. This period is compared to the four weeks that began last year on Monday, January 8 and ended on Sunday, Februa ...